RARA CRAFT DATABASE for FDA Medical Devices
510(k)K242683

FDA DEVICE FACTS

QP-Prostate® CAD

Quibim S.L.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEMarch 18, 2025PRODUCT CODEQDQCLINICAL AREARadiology

Indications for use

QP-Prostate® CAD is a Computed Aided Detection and Diagnosis (CADe/CADx) image processing software that automatically detects and identifies suspected lesions in the prostate gland based on bi-parametric prostate MRI. The software is intended to be used as a concurrent read by physicians with proper training in a clinical setting as an aid for interpreting prostate MRI studies. The results can be displayed in a variety of DICOM outputs, including identified suspected lesions marked as an overlay onto source MR images. The output can be displayed on third-party DICOM workstations and Picture Archive and Communication Systems (PACS). Patient management decisions should not be based solely on the results of QP-Prostate® CAD. Intended patient population: Patients above 40 years with prostate MR imaging. Intended users: QP-Prostate® CAD is intended to be used by physicians with proper training, including radiologists, urologists and any physician qualified to read and interpret prostate MRI consistent with ACR recommendations in the context of PI-RADS.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026